between 11 and 32 days of age. The known increase in mouse serum testosterone to adult male levels between 4-12 wk of age Using specific and sensitive radioimmunoassa~s for may be a factor in the late increase in NGF and EGF elevations growth factor (NGF) and epidermal growth factor (EGF), we after 32 days of age. studied the developmental profde of NGF and EGF concentrations in male mouse submaxillary gland (SMG) from 2-60 days of age. We measured NGF concentrations in mouse cerebellum, cerebral Nerve growth factor (NGF) and epidermal growth factor (EGF) cortex, and brain stem from ages 2-32 days. In addition, we are found in highest concentrations in the submaxillary gland assessed mouse serum thyroxine (T4) and triiodothyronine (T3) (SMG) of the adult male mouse (13, 22) . Both proteins are found levels in SePerate groups of animals ranging from 5-50 days of in peritubular cells (32, 35) and are released concomitantly into age. Mean SMG EGF content and concentration exceeded that saliva (16, 27) . ~0 t h have C-terminus arginine residues (2, 13) and of NGF between 2 and 18 days of age. At all subsequent ages, exist in SMG as high molecular weight complexes with specific however, mean NGF and EGF content and concentration were arginine esteropeptidase subunits (34). In addition, both NGF, similar. SMG NGF and EGF content were low at 2 days of age, and EGF are found in higher concentrations in male than in decreased slightly through 8 days of age, and increased exponen-female glands. The concentration of both peptides in SMG is tially after 11 days of age with three phases of increase being increased by androgens (10, 17). Bynny et al. (9) described the apparent for both proteins. In the first phase, mean SMG NGF ontogenetic profile of radioimmunoassayable SMG EGF content and EGF contents increased 2.4 and 2.3-fold respectively between from 15 days ofage through adulthood. ~l~~ and ~~~i -~~~ 11 and 18 days of age. A second phase of increase was noted (3) have traced the developmental pattern of SMG NGF concenbetween 18 and 32 days when NGF and EGF increased 9g45-and trations after 20 days using an in vitro bioassay. Murphy et al. (26) 7805-fold respectively. In phase three (32-60 days of age) more have suggested that NGF and EGF are present in equal concenmodest increases of 6.5-fold in mean NGF and EGF content were trations in mature male mouse SMG; however, simultaneous noted.
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In earlier reports we have described significant concentrations plateau level of 1304 pg/mg protein by age 18 days. Cerebral of radioimmunoassayble NGF in brain tissue of adult and develcortical NGF concentrations increased steadily from 251 to 1383 oping mice (37, 40) but have not developed a complete ontogenetic p d m g protein between ages 2 and 32 days, w l~r e a s brain stem profile; moreover, we have found that brain tissue contains no NGF concentrations maintained a plateau averaging 1100 pg/mg EGF (41). The present report describes studies of the developprotein.
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MATERIALS AND METHODS

Speculation
Animals. Swiss-Webster mice were obtained from Simonsen We and others have demonstrated that thyroid hormones in-Laboratories, Gilroy, CA. Animals were received 1-2 days before crease brain NGF concentrations and stimulate submaxillary sacrifice and were housed in a temperature-(24" + 1°C) and gland NGF and EGF synthesis. The present results are compatible light-controlled (14 h light) room. Humidity was not controlled. with the hypothesis that the early increase in circulating thyroid Litters of eight male pups were housed with the dams in single hormone concentrations in the mouse play an important role in cages. Postweanling mice were housed five/cage. Male mice for the increase in cerebral and cerebellar NGF levels during the first SMG studies were killed at 2, 5, 8, 11, 17, 18, 21, 28, 32, 40, and 3 wk and the increase in SMG NGF and EGF concentrations 60 days of age. Pooling of SMG tissue was required for data 520 points in the younger age groups in order to yield suff~cient material for measurement. At all ages a minimum of eight samples or pools was used for each data point. Maternal influences were obviated by pooling across litters. Brain regions were studied in separate groups of male animals at ages 2, 5, 12, 15, 17, 18, 20, and 32 days; brain tissue from three or two animals was pooled for each of 5-10 data points at early and later ages respectively. In a third set of experiments, trunk blood from mice killed at ages 5, 10, 15, 20, 25, 30,40 and 50 days was collected for determination of serum thyroxine (T4) and triiodothyronine (T3) concentrations. This blood was centrifuged at 5000 X g for 10 min at 4°C and the sera pooled. Serum from 32 animals was pooled for measurements at ages 5 and 10 days and from 16 animals at later ages. Between 6-8 serum pools then were used for each data point.
SMG's were removed on ice. Brains were removed on ice and immediately dissected into cerebral cortex (excluding cerebral white matter and hippocampal formation), cerebellum, and brain stem fractions (below the inferior colliculus). SMG and brain tissues were weighed and homogenized in 10 and 5 volumes, respectively, of phosphate buffered saline (PBS) pH 7.2 at 4OC. The supernatant, recovered after centrifugation at 2,5000 X g for 30 min at 4OC, was frozen pending radioimmunoassay (RIA) measurement of EGF and/or NGF.
RIA for NGF and EGF. NGF and EGF were purified from male mouse SMG (25, 31) and used as iodination and reference preparations. Both purified NGF and EGF yielded single bands on sodium dodecyl sulfate polyacrylamide gel electrophoresis. Supernatant NGF and EGF concentrations were measured by specific double antibody RIA techniques (38, 39) . All samples were assayed at two dilutions in the same RIA run. The RIA for /3-NGF can quantify 10-20 pg /3-NGF and cross-reacts completely with the large molecular weight (140,000) 7s storage form of NGF in the SMG. The EGF RIA is sensitive to 20-30 pg EGF (MW 6000) and also cross-reacts with the larger (MW 74,000) SMG storage form. Intraassay coefficients of variation for NGF and EGF were 7.5% and 6.1% respectively. Cross-reaction of NGF in the RIA for EGF was 0.009%, and EGF cross-reaction in the NGF RIA was <0.001%. Submandibular gland renin did not cross-react in either RIA. Recoveries of added purified NGF and EGF from tissue homogenates approximated 100% and the dose response curve for the tissue extract of each hormone was parallel to the standard curve.
Supernatant protein concentrations were determined by the Folin-phenol method of Lowry et al. (24) , using bovine serum albumin as standard.
RIA for T4 and T3. Mouse serum T4 was measured by the RIA method of Chopra (1 1); hypothyroid sheep serum with added Lthyroxine (Sigma) was used for standard curves. Serum T3 also was measured by RIA (12) using L-triiodothyronine (Sigma) as the reference preparation. IlZ5 labeled T4 and T3 were purchased from Nichols Institute, San Pedro, Calif. Figure 1 illustrates the ontogenetic profile of male SMG NGF and EGF contents (ng/mg wet weight; upper panel) and SMG wet weight (lower panel) as a function of increasing postnatal age. Mean SMG NGF and EGF contents had virtually identical developmental patterns. Between 2-18 days of age, SMG EGF content exceeded that of NGF. After 21 days, however, mean SMG NGF and EGF contents were virtually indistinguishable.
RESULTS
Both mean NGF and EGF contents declined slightly from 2-8 days of age. After 11 days SMG NGF and EGF contents increased exponentially. Three major phases of increase were apparent for both proteins. Between 11-18 days both NGF and EGF content increased by 2.4-and 2.3-fold respectively to values similar to those observed at 2 days of age. Between 18-32 days of age, mean SMG NGF and EGF contents increased 9845-and 7805-fold, respectively. The third phase of increase occurred between 32-60 days when concentrations of NGF and EGF each increased some 6.5 times. In contrast to the exponential increases in mean SMG NGF and EGF content, mean SMG weights (Fig. 1, lower panel) increased linearly some 8-10-fold between 2-60 days of age.
Examination of the increase in mean SMG NGF and EGF concentrations expressed relative to the SMG protein concentrations ( Fig. 2 upper and lower panels) revealed similar developmental profiles. Mean SMG NGF and EGF concentrations decreased slightly between 2-1 1 days, then increased to day 2 levels by 18 days of age. Marked increases in NGF and EGF concentrations were observed between 18 and 32 days of age and further increments were noted between 32-60 days of age. Mean SMG protein concentrations (Figure 2 , lower panel) increased linearly in parallel with mean SMG weights. Figure 3 illustrates the ontogenetic profile of mean NGF levels in the three brain regions. Mean cerebellar NGF concentration increased from 681-2241 pg/mg protein between ages 2-15 days, and subsequently fell to a plateau level of 1304 pg/mg protein by age 18 days. Cerebral cortical NGF increased steadily from 25 1-1383 pg/mg protein between ages 2-32 days, whereas brain stem NGF concentrations maintained a plateau averaging 1100 pg/mg protein. Figure 4 demonstrates that serum T4 concentrations increased dramatically from a mean of 2.5 /@dl at age 5 days to a maximum concentration of 8.1 &dl at age 15 days. The mean level decreased to a nadir of 4.4 pg/dl by 40 days. Mean serum T3 concentrations followed a similar pattern, increasing from 25 ng/ dl on postnatal day 5 to 93 ng/dl on day 15. A subsequent decline to 63 ng/dl occurred between 15-30 days and a slight rise was observed thereafter.
DISCUSSION
These data indicate marked and dynamic changes in mean SMG NGF and EGF contents and concentrations during postnatal life in the male mouse. They are the first reported observations of the ontogeny of both NGF and EGF in the same SMG measured by sensitive and specific RIA techniques. The present results are in general agreement with those of Bynny et al. (9) for EGF and Aloe and Levi-Montalcini (3) for NGF. Both groups reported exponential increases in SMG EGF and NGF concentrations from 15-20 days of age through adulthood. The NGF data of Aloe and Levi-Montalcini (3) were derived by bioassay whereas we report RIA concentrations. Both the bioassay and RIA methods measure either free PNGF or the 7s (MW 140,000) storage complex. SMG NGF in gland homogenates has been shown to exist predominantly as the large molecular weight complex (38) . SMG EGF is present both in the 6000 MW form and the 74,000 MW complex (39) .
Our results confirm the exponential increases in SMG NGF and EGF reported earlier (3, 9) and in addition, on the basis of more frequent samplings, demonstrate three phases of increase ( Fig. 1,2 ). In the first phase (1 1-18 days of age), NGF and EGF contents increased 2.4-and 2.3-fold respectively. During the second phase (18-32 days), 9845-and 7805-fold increases in NGF and EGF concentrations were noted. A third phase showed progressive increases of 6.5-fold between 32-60 days of age; thus, there is marked similarity in the patterns of accumulation of both NGF and EGF in the SMG. Both the initial decreases and subsequent increases in NGF and EGF concentrations during postnatal life are strikingly concordant; moreover, mean SMG NGF and EGF concentrations in the adult (60-day-old) mouse are similar ( Fig. 1 and 2 ) in agreement with earlier reports (26, 39) . The factors responsible for the observed developmental patterns of NGF and EGF in SMG may be similar, although the predominant factor(s) during early postnatal life may well be different from those operative in mature animals.
The present ontogentic studies of NGF in brain tissue represent the first data available in any species. The molecular form of the brain NGF is not known; the present RIA reacts with PNGF or the larger storage molecule. In a recent report, we have demonstrated NGF bioactivity in adult mouse brain homogenate, but direct comparisons of bioactivity and RIA concentrations were not possible due to the semiquantitative nature of the bioassay and the low NGF concentrations (33). It is not known whether brain NGF levels have any significance in brain maturation. We have reported earlier that thyroid hormone administration increases NGF concentrations in brain tissue in neonatal as well as adult mice (37, 40) . Aloe and colleagues (4) have reported recently that neonatal mice, which received NGF antiserum injection in utero, demonstrate hypothyroid-like behavior in the neonatal period.
Assuming that brain NGF levels are related to brain development, it is of interest to relate the NGF concentrations changes to the developmental morphologic events. The 3-fold rise and subsequent fall in cerebellar NGF concentrations (Fig. 3) occur at a postnatal age immediately after the time of maximum cell replication in the cerebellar external granular layer in rats and mice (19) and correponding to the onset of increased inward granule cell migration <21), el;ngation of parallel fibers (20) , synaptogenesis (28) . and further dendritic arborization and cellular differentiatidn. 1n the cerebral cortex (Fig. 3) , the continuously progressive 5-fold increase in NGF concentration during the first 4 postnatal wk appears to parallel the migration to the cortex of late forming cerebral neurons from the periventricular germinal zone. During this period there is a progressive increase in density of cortical axons, dendritic arborizations, and synaptogenesis (18) .
The relatively flat developmental profile for postnatal mouse brain stem NGF (Fig. 3) is compatible with the fact that murine brain stem development occurs prenatally in order to accomodate the vegitative functions of the suckling animal. In both the mouse (30) and rat (5) (6) (7) (8) , neurons from nuclei at various levels of the brain stem have been shown to originate well before parturition. Brain stem growth in both the neonatal mouse and rat is less pronounced than in other brain areas, suggesting that cellular proliferation and differentiation are nearing completion during the neonatal period. Thus the three major brain regions have different time tables of development, and NGF concentrations in each region correspond with-the ontogenetic period related to cellular differentiation. It must be reem~hasized. however. that a role for NGF in brain development rem'ains enthely spec;lative.
It is of interest that NGF levels in the brain tissues do not parallel the ontogenetic profile of NGF in SMG. The significance of SMG NGF is not known (27) . The SMG may contribute to circulating NGF concentrations, but sialectomy does not markedly reduce circulating NGF (RIA) levels (27) ; moreover, NGF does not cross the blood-brain barrier (I), and reports indicate that CNS cells from both human (29) and rat (23) produce NGF in vitro. The NGF levels measured in brain tissue presumably reflect local production. The observation of nonparallel changes in SMG and brain NGF concentrations observed in the present study are compatible with this hypothesis. The levels of SMG and brain NGF are approximately the same order of magnitude during the first 1-2 wk of life but by 30 days, SMG levels exceed brain concentrations by some three orders of magnitude.
Our data (Fig. 4) , describing the developmental profile of serum T4 and T3 in the mouse, are the only available ontogenetic data for thyroid hormones in this species. The data for mouse correspond in general to data described for rat (15, 36) where serum total and free T4 and T3 concentrations are low at birth and increase progressively during the first 3-4 wk of postnatal life (15, 36) . In the mouse, (Fig. 4) the peak of serum T3 concentration appears to coincide at age 15 days with that of T4, whereas in the rat T3 levels are maximum at 3-4 wk of age (15) compared with a T4 peak at age 2 wk (15). We and others have shown that thyroid hormones markedly increase NGF concentrations in adult as well as neonatal mouse SMG (3, 38, 39) . In earlier reports we have documented that thyroid hormone administration increases EGF levels in SMG of adult mice (39) and increases NGF levels in adult and neonatal mouse brain (37, 40) . The timing of the increase in circulating thyroid hormone levels in the mouse is compatible with the view that thyroid hormones may play a role in the pronounced increase in SMG NGF and EGF concentrations between 11 and 32 days of age, as well as the increases in cerebellar NGF between 2 and 15 days and the progressive increase in cerebral NGF levels between 2 and 32 days. Further studies are necessary to prove this hypothesis.
NGF and EGF concentrations also are known to be androgen dependent and levels of both are higher in adult male than in adult female SMG (10, 22, 27) ; however, serum testosterone levels remain below 1 ng/ml before 26 days gestation (14) only increasing to adult levels between 4-12 wk of age. Thus, circulating androgens are not likely to be a major factor in the marked increase in SMG NGF and EGF between 18-32 days. Androgen may, however, play a role in the third phase increases in SMG NGF concentrations.
